Registration and information: www.virology-education.com

1ST CENTRAL AND EASTERN EUROPEAN WORKSHOP ON

WARSAW, POLAND • 22 - 23 JUNE 2015

VIRAL HEPATITISAND CO-INFECTION WITH HIV

ORGANIZING COMMITEESvitlana Antonyak, MD Academy of Medical Sciences, Kiev, Ukraine

Jürgen Rockstroh, MD University of Bonn, Germany

Charles Boucher, MD, PhD Erasmus Medical Centre, Rotterdam, the Netherlands

Jonathan Schapiro, MD Sheba Medical Center, Israel

Andrzej Horban, MD, PhD Hospital for Infectious Diseases, Warsaw, Poland

Adrian Streinu Cercel, MD, PhD Nat. Institute for Inf. Diseases “Prof. Dr. Matei Bals”, Bucharest, Romania

Pavel Khaykin, MD MainFachArzt, Frankfurt, Germany

Alicja Wiercinska – Drapało, MD, PhD Medical University of Warsaw, Poland

Vadim Rassokhin, PhD, Center for the Prevention and Control of AIDS and Inf. Diseases, St. Petersburg, Russia

Cihan Yurdaydin, MDUniversity of Ankara Medical School, Turkey

SCIENTIFIC COMMITTEE

Krasimir Antonov, MD, PhD - ”St.Ivan Rilski” University Hospital, Sofia, Bulgaria

Dénes Bánhegyi, MD - National Institute for Health Promotion, Budapest, Hungary

Saulius Caplinskas, MD, PhD - Centre for Communicable Diseases and AIDS, Vilnius, Lithuania

Peter Jarcuska, MD, PhD - PJ Šafárik University, Košice, Slovakia

Brygida Knysz, MD, PhD - Medical University of Wroclaw, Wroclaw, Poland

Mojca Maticic, MD, PhD - University Medical Centre, Ljubljana, Slovenia

Cristina Popescu, MD, PhD - National Institute for Infectious Diseases “Prof. Dr. Matei Bals”, Romania

Dalibor Sedlácek, MD, PhD - University Hospital of Pilzen, Pilzen, Czech Republic

Tengiz Tsertsvadze, MD, PhD - AIDS and Clinical Immunology Research Center, Tbilisi, Georgia

WHO SHOULD ATTEND?

Healthcare professionals involved in daily care for HCV patients such as infectious disease doctors, gastro-enterologists, hepatologists and others.

WHO SHOULD ATTEND?

• This new independent program is developed by regional and international Key Opinion Leaders for the medical and scientific community in Eastern and Central Europeancountries.

• This meeting aims to provide a unique and much needed platform for scientific and medical interchange and education on treatment of Viral Hepatitis and Co-infection with HIV.

• It is a focused meeting to address regional challenges and to build collaborations in order to advance the field.

Free registration for young investigators and Academia

with accepted abstracts!

PRELIMINARY PROGRAMMONDAY 22 JUNE

08.30 h Registration, welcome coffee

10.00 h Opening of the Workshop

Session 1 HIV-HCV Coinfection: Situation in Central-Eastern Europe

10.15 h Opening Lecture: Epidemiology of HIV-HCV Coinfection in Central-Eastern Europe

10.15 h Local Situation in Poland - Milosz Parczewski, MD, PhD, Pomeranian Medical University in Szczecin, Poland

10.30 h Local Situation in Ukraine - Larisa Moroz, MD, PhD, Vinnitsa National Medical University, Ukraine

10.45 h Local Situation in Russia - Vadim Rassokhin, PhD, State Healthcare Institution Center for the Prevention and Control of AIDS and Infectious Diseases, Russia

11.00 h Local Situation in Romania - Adrian Streinu Cercel, MD, PhD, Matei Bals Infectious Diseases Institute, Bucharest, Romania

11.15 h Local Situation in Baltic Countries - Saulius Caplinskas, MD, PhD, Lithuanian Center for Communicable Diseases and AIDS, Lithuania

11.30 h Local Situation in Georgia - Tengiz Tsertvadze, MD, PhD, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia

11.45 h Local Situation in Czech and Slovak Republics - Dalibor Sedlacek, MD, PhD - University Hospital of Pilzen, Pilzen, Czech Republic (inv.)

12.00 h Local Situation in Turkey - Cihan Yurdaydin, MD, - University of Ancara Medical School, Turkey

12.15 h Panel discussion

13.00 h Lunch

14.00 h Satellite Symposium

15.30 h Coffee Break

Session 2 Management ol Hepatitis C

16.00 h Natural History of HCV Infection - Krzysztof Simon, MD, PhD, Medical University of Wroclaw, Poland

16.30 h Management of End-stage Liver Disease - Massimo Puoti, MD, Niguarda Cà Granda Hospital, Italy

17.00 h State of the Art Treatment of HCV (tbc)

17.30 h Management of Drug Drug Interactions - David Back, PhD, University of Liverpool, United Kingdom

18.00 h Adjournment

An application has been made to the EACCME® for CME accreditation of this event

TUESDAY 23 JUNE

08.00 h Satellite Symposium

Session 3 Clinical Management of Hepatitis B Infection

09.00 h Epidemiology of Hepatitis B in Central and Eastern Europe - Adrian Streinu Cercel, MD, PhD, Matei Bals Infectious Diseases Institute, Bucharest, Romania

09.30 h State of the Art Treatment of Hepatitis B - Maria Buti, MD, PhD, Hospital Vall d’Hebron, Spain

10.00 h Abstract - driven presentations

10.30 h Coffee Break

11.00 h Satellite Symposium

12.30 h Lunch

Session 4 Clinical Management of Hepatitis C infection in Special Patient Populations

13.30 h Acute Hepatitis C Infection - Christoph Boesecke, MD, PhD, University of Bonn, Germany

14.00 h Treatment of HBV and HCV in HIV - Sanjay Bhagani, BSc FRCP, Royal Free Hospital, UK

14.30 h Abstract - driven presentations

15.00 h Coffee Break

Session 5 Treatment Challenges & Access Issues

15.30 h An Integrated Approach to HCV Treatment in People who Inject Drugs Cross Europe - Mojca Maticic, MD, PhD, University Medical Centre, Ljubljana, Slovenia

16.00 h Care Models for Hepatitis Therapy (tbc)

16.30 h Round table discussion: HCV Therapy: Cure for all or Still Improvements to Come?

17.00 h Closing Remarks